UT Health San Antonio faculty member helps create universal long COVID definition

July 31, 2024

A report released June 11 by the National Academies of Sciences, Engineering and Medicine (NASEM) provides a working definition of long COVID. Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Rehabilitation Medicine in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San […]


$11 million NIH grant awarded for five-year investigation of novel oral chlamydia vaccine

May 2, 2024

The study of a novel oral vaccine that could protect against chlamydia infection received more than $11 million in National Institutes of Health funding through a five-year U01 grant in April 2024. “We are excited about receiving the U01 award because it will enable us to move our basic microbiology and immunology bench research work […]


UT Health San Antonio, Ohio company reach license agreement to develop chlamydia vaccine

December 13, 2022

Vaccines for this infection have been challenging to produce SAN ANTONIO (Dec. 13, 2022) — The University of Texas Health Science Center at San Antonio has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease […]




UT Health San Antonio physicians offer advice for flu, RSV, COVID-19 triple threat

December 9, 2022

  Unlike triple threats celebrated in sports and the entertainment world, no one is celebrating the possibility of a triple threat of the flu, respiratory syncytial virus, or RSV and COVID-19. With the winter holidays fast approaching, UT Health San Antonio physicians are encouraging the community to get vaccinated for both the flu and COVID-19, […]